Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
PMID: 37120548
The muscle loss associated with GLP-1 drug use is particularly concerning in older adults (50+) whose muscle mass and bone density is typically declining due to aging anyway, increasing the risk of fractures and falls, even fatal ones
Liraglutide , marketed under the brand name Saxenda, is one such treatment approved for chronic weight management in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related condition
The risk of hypoglycaemia with GLP-1 medications is generally low unless they are used in combination with insulin or sulfonylureas
2023;39(8):e3699
US$ 27.34
US$ 29.84
US$ 20.64
US$ 22.32
US$ 21.86
US$ 21.38
US$ 21.76
US$ 22.17
US$ 22.57
